Drug maker Johnson amp Johnson was ordered to pay disgruntled partner Amgen Inc. 457 million in a dispute over sales of the anemia fighting drug, biotechnology's best selling product.
Johnson amp Johnson ordered to pay Amgen 457 million in dispute over sales.